Lista de obras - Emiliano Fabiani - Dominio Público Uruguay

A case of SRSF2 mutation in chronic lymphocytic leukemia

artículo científico publicado en 2016

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

artículo científico publicado en 2015

Correction to Barbetti V, et al. Epigenetics Volume 8, Issue 2; pp. 210–9.

artículo científico publicado en 2013

Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? - Response to Lucijanic and Kusec

artículo científico publicado en 2019

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes

artículo científico publicado en 2019

Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes

artículo científico publicado en 2014

Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia.

artículo científico publicado en 2015

Epigenetic changes in therapy-related MDS/AML.

artículo científico publicado en 2009

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

artículo científico publicado en 2015

Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

article

Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations

scientific article published on 23 April 2019

In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome

scientific article published on 08 April 2020

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes

scientific article published on 01 September 2007

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms

artículo científico publicado en 2014

Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies

scientific article published on 04 May 2014

Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS)

artículo científico publicado en 2018

Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia

artículo científico publicado en 2021

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

artículo científico publicado en 2012

Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy

artículo científico publicado en 2014

Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes

artículo científico publicado en 2008

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

artículo científico publicado en 2006

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine

artículo científico publicado en 2011

SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

artículo científico publicado en 2014

Similarities and differences between therapy-related and elderly acute myeloid leukemia.

artículo científico publicado en 2011

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes

scientific article published on 01 November 2013

The Role of Forkhead Box Proteins in Acute Myeloid Leukemia

scientific article published on 21 June 2019

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

artículo científico publicado en 2009

Why methylation is not a marker predictive of response to hypomethylating agents.

scientific article published on April 2014

Lista de obras de Emiliano Fabiani

A case of SRSF2 mutation in chronic lymphocytic leukemia

Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias

Correction to Barbetti V, et al. Epigenetics Volume 8, Issue 2; pp. 210–9.

Could haemochromatosis (HFE) gene mutations affect response to iron chelation in myelodysplastic syndrome? - Response to Lucijanic and Kusec

Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic Syndromes

Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes

Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia.

Epigenetic changes in therapy-related MDS/AML.

Fanconi anemia gene variants in therapy-related myeloid neoplasms.

Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine

Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations

In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome

Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes

Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms

Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies

Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS)

Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases.

Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy

Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine

SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.

Similarities and differences between therapy-related and elderly acute myeloid leukemia.

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes

The Role of Forkhead Box Proteins in Acute Myeloid Leukemia

Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.

Why methylation is not a marker predictive of response to hypomethylating agents.